Director James P. Mackin notifies planned share sales (NYSE: AORT)

Rhea-AI Filing Summary

AORT insider filing reports proposed and recent share dispositions by James P. Mackin. The notice lists a proposed sale of 13,936 common shares delivered on 02/23/2026 tied to restricted stock vesting and shows three reported sales in the prior three months: 30,921 shares on 12/02/2025 for $1,408,736.02, 30,921 shares on 12/03/2025 for $1,405,693.40, and 20,962 shares on 02/23/2026 for $787,909.17.

Insights

Insider Transactions Compliance

Form 144 documents proposed and recent insider sales by James P. Mackin.

The filing lists a proposed disposition of 13,936 common shares on 02/23/2026 described as "Restricted Stock Vesting" and records three prior sales in the covered three‑month period with exact share counts and proceeds.

These entries align with routine insider reporting requirements; timing, method of sale, and any trading plan details are not provided in the excerpt, so subsequent filings would contain additional execution details if and when trades occur.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	13936	497416.25	47883897	02/24/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/23/2026	Restricted Stock Vesting	Issuer			13936	02/23/2026	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
James P. Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	12/02/2025	30921	1408736.02
James P. Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	12/03/2025	30921	1405693.40
James P. Mackin 1655 Roberts Boulevard N.W. Kennesaw GA 30144	Common	02/23/2026	20962	787909.17

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What did AORT insider James P. Mackin report in the Form 144?

The Form 144 reports a proposed sale of 13,936 restricted common shares on 02/23/2026 and three recent sales: 30,921, 30,921, and 20,962 shares with stated proceeds in the filing.

Does the Form 144 show proceeds for the recent AORT share sales?

Yes. The filing lists proceeds of $1,408,736.02, $1,405,693.40, and $787,909.17 tied to the reported sales on 12/02/2025, 12/03/2025, and 02/23/2026, respectively.

Are the proposed AORT shares being sold from a vesting event or open‑market sale?

The excerpt describes the 13,936 proposed shares as resulting from a "Restricted Stock Vesting" event on 02/23/2026. The filing does not specify the planned sale method in this excerpt.

Who filed the Form 144 for AORT and what is the insider's role?

The filing shows transactions associated with James P. Mackin. The provided excerpt does not state a formal corporate title for him; it lists his address and the reported share transactions.

How recent are the reported AORT transactions in the Form 144?

Reported transactions span 12/02/2025 and 12/03/2025 sales of 30,921 shares each and a 02/23/2026 sale of 20,962 shares, plus the proposed 13,936 vested shares on 02/23/2026.